Rankings
▼
Calendar
IOBT FY 2023 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena
IOBT
IO Biotech, Inc.
$21M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$756,000
Operating Income
-$91M
Net Income
-$86M
EPS (Diluted)
$-1.98
Cash Flow
Operating Cash Flow
-$72M
Free Cash Flow
-$72M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$151M
Total Liabilities
$18M
Stockholders' Equity
$133M
Cash & Equivalents
$143M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$756,000
-$540,000
-40.0%
Operating Income
-$91M
-$71M
-28.0%
Net Income
-$86M
-$71M
-20.5%
← Q4 2022
All Quarters
Q1 2023 →